Join Now

Category Archives: Industry News

IONIQ Sciences Announces Dr. Raphael E. Pollock Has Joined Its Medical Advisory Committee

IONIQ Sciences, Inc. recently announced that Raphael E. Pollock, MD, PhD, FACS has joined its Medical Advisory Committee. Dr. Pollock is an award-winning surgical oncologist, extensively published physician- scientist, Professor Emeritus in the Department of Surgical Oncology at MD Anderson Cancer Center and currently the Director of The Ohio State University Comprehensive Cancer Center (OSUCCC). […]

Also posted in BioUtah News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

American Society of Nephrology and Renalytix Co-Host Virtual Capital Markets Day for Kidney Health

RenalytixAI co-hosted a Capital Markets Day for Kidney Health with the American Society of Nephrology yesterday, Feb. 11. The virtual event brought together a broad group of delegates representing the kidney community, including leading clinicians, representatives of U.S. government health agencies, kidney care innovators and investors focused on life sciences and medical technology, for a […]

Also posted in BioUtah News, Utah's Life Sciences Companies | | Leave a comment

Attostat is now EVŌQ Nano – Seeks Next Round of Investment Following Antimicrobial Efficacy Studies

Attostat is now EVŌQ Nano! The Utah start-up has a new name, a clean look and a fresh website. Following years of scientific research and development, EVŌQ Nano is ready to share its story of next-generation nanotechnology and raise its next round of investment. “We truly are a thought leader in nanotechnology,” said CEO Scott […]

Also posted in BioUtah News, Utah's Life Sciences Companies | | Leave a comment

Novel Embolic Device Used for Arterial and Venous Tumor Treatments

Fluidx Medical Technology has announced successful patient use of the GPX Embolic Device to therapeutically devascularize, or block blood supply to, a tumor. The GPX Embolic Device is an innovative embolic designed to combine the benefits of other embolics like coils, particles, and liquids with simplified preparation, delivery, precision, and control leading to durable, long-term […]

Also posted in BioUtah News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

Spectrum Solutions Collaborates with UCLA on Saliva-Based Next-Gen Sequencing (NGS) Liquid Biopsy Research for the Early Detection of Lung Cancer

Study to focus on using saliva in the analysis of cell-free circulating tumor DNA (ctDNA) to accurately and non-invasively detect non-small cell lung cancer (NSCLC). Business Wire: January 27, 2021 08:00 AM Eastern Standard Time “SALT LAKE CITY–(BUSINESS WIRE)–Spectrum Solutions, LLC today announced its sponsored research collaboration with the UCLA School of Dentistry for a […]

| Leave a comment

Control Medical Technology Announces New Device Removes Large Blood Clots in 1st Deep Vein Thrombosis (DVT) Patient Use

Control Medical Technology today announced the FDA cleared Control 11F Mechanical Thrombectomy system was used to remove large blood clots from patients with deep vein thrombosis (DVT). The system is Utah born, designed, engineered, patent prosecuted, and manufactured. “The Control 11 French Mechanical Thrombectomy System can remove large clots,” said Shawn Fojtik, President of Control […]

Also posted in Policy News, Utah's Life Sciences Companies | | Leave a comment

Entrepreneur Your Startup – Get a Master’s Degree

Calling all life sciences early stage founders and startups! In partnership with the Lassonde Entrepreneur Institute at the University of Utah, the University’s David Eccles School of Business is now accepting applications to join its Master of Business Creation (MBC) program for 2021-2022. The priority application deadline is Feb. 12, 2021. This nine-month, professional-degree program […]

Also posted in BioUtah News | | Leave a comment

Co-Diagnostics Anticipates Reporting Highest Quarterly Revenue Following Demand for COVID-19 Diagnostic Products

Based on its preliminary internal financial reporting for the fourth quarter 2020, Co-Diagnostics has announced that unaudited quarterly revenue for the company is anticipated to be the highest in the company’s history and to surpass analyst estimates. Analysts’ estimates for the fourth quarter ranged from $24 million to $25.98 million. Quarterly revenue is anticipated to […]

Also posted in BioUtah News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

Early Risk Identification at Core of Innovative Kidney Care Partnership Between Renalytix, DaVita

Kidney care innovators Renalytix AI and DaVita are partnering on a new program aimed at slowing disease progression and improving health outcomes for the nation’s estimated 37 million adults with chronic kidney disease (CKD). This first of its kind program is expected to improve patient outcomes and provide meaningful cost reductions for healthcare providers and […]

Also posted in BioUtah News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

IONIQ Sciences Designated ‘Most Innovative Cancer Detection and Diagnostics Technology Firm’ by CV Magazine

12/10/2020 – IONIQ Sciences has been designated as 2020’s ‘Most Innovative Cancer Detection and Diagnostics Technology Firm’ by CV Magazine. Our goal to modernize cancer testing has taken us to exciting heights this year. We resolutely believe in our potential to introduce a ‘breakthrough’ Multi-Cancer Screen that will non-invasively detect the presence of malignancy in its earliest stages utilizing our Electrical Impedance Analytics […]

Also posted in Life Sciences Industry News | | Leave a comment

Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in the Dubermatinib Arm of The Leukemia & Lymphoma Society’s Beat AML Master Clinical Trial in Patients with Acute Myeloid Leukemia

Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today announced the first patient has been dosed in a Phase 1b/2 study evaluating the oral investigational agent, dubermatinib (TP-0903), an AXL kinase inhibitor, in combination with decitabine, in patients 60 years or older with newly diagnosed acute myeloid leukemia (AML) who have TP53 […]

Also posted in BioUtah News, Life Sciences Industry News | | Leave a comment

Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 2 of Cancer Study

Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today announced the first patient has been dosed in the Phase 2 expansion portion of the study evaluating DSP-7888, an investigational immunotherapeutic cancer vaccine that targets Wilms Tumor 1 (WT1), in combination with checkpoint inhibitor pembrolizumab, in patients with platinum-resistant ovarian cancer (PROC). The […]

Also posted in BioUtah News, Life Sciences Industry News | | Leave a comment